Abstract
We have developed a mouse severe combined immunodeficient (SCID) model of myocardial infarction based on permanent coronary artery occlusion that allows long-term functional analysis of engrafted human embryonic stem cell-derived cardiomyocytes, genetically marked with green fluorescent protein (GFP), in the mouse heart. We describe methods for delivery of dissociated cardiomyocytes to the left ventricle that minimize scar formation and visualization and validation of the identity of the engrafted cells using the GFP emission spectrum, and histological techniques compatible with GFP epifluorescence, for monitoring phenotypic changes in the grafts in vivo. In addition, we describe how magnetic resonance imaging can be adapted for use in mice to monitor cardiac function non-invasively and repeatedly. The model can be adapted to include multiple control or other cell populations. The procedure for a cohort of six mice can be completed in a maximum of 13 weeks, depending on follow-up, with 30 h of hands-on time.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
van Laake, L.W., Hassink, R., Doevendans, P.A. & Mummery, C. Heart repair and stem cells. J. Physiol. 577, 467–478 (2006).
Iso, Y. et al. Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem. Biophys. Res. Commun. 354, 700–706 (2007).
Muller-Ehmsen, J. et al. Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J. Mol. Cell Cardiol. 41, 876–884 (2006).
Menard, C. et al. Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet 366, 1005–1012 (2005).
Orlic, D. et al. Bone marrow cells regenerate infarcted myocardium. Nature 410, 701–705 (2001).
Orlic, D. et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. U.S.A 98, 10344–10349 (2001).
Zhang, S. et al. Host vascular niche contributes to myocardial repair induced by intracoronary transplantation of bone marrow CD34+ progenitor cells in infarcted swine heart. Stem Cells 25, 1195–1203 (2007).
Rosenzweig, A. Cardiac cell therapy—mixed results from mixed cells. N. Engl. J. Med. 355, 1274–1277 (2006).
van Laake, L.W. et al. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res. http://dx.doi.org/10.1016/j.scr.2007.06.001.
Huang, N.F. et al. A rodent model of myocardial infarction for testing the efficacy of cells and polymers for myocardial reconstruction. Nat. Protoc. 1, 1596–1609 (2006).
van Oort, R.J. et al. MEF2 activates a genetic program promoting chamber dilation and contractile dysfunction in calcineurin-induced heart failure. Circulation 114, 298–308 (2006).
van Laake, L.W. et al. Endoglin has a crucial role in blood cell-mediated vascular repair. Circulation 114, 2288–2297 (2006).
Yutzey, K.E. & Robbins, J. Principles of genetic murine models for cardiac disease. Circulation 115, 792–799 (2007).
Mummery, C. et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 107, 2733–2740 (2003).
Passier, R. et al. Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures. Stem Cells 23, 772–780 (2005).
Behfar, A. et al. Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. J. Exp. Med. 204, 405–420 (2007).
Tomescot, A. et al. Differentiation in vivo of cardiac committed human embryonic stem cells in post-myocardial infarcted rats. Stem Cells 25, 2200–2205 (2007).
Costa, M. et al. The hESC line Envy expresses high levels of GFP in all differentiated progeny. Nat. Methods 2, 259–260 (2005).
Doevendans, P.A., Becker, K.D., An, R.H. & Kass, R.S. The utility of fluorescent in vivo reporter genes in molecular cardiology. Biochem. Biophys. Res. Commun. 222, 352–358 (1996).
Laflamme, M.A. et al. Formation of human myocardium in the rat heart from human embryonic stem cells. Am. J. Pathol. 167, 663–671 (2005).
Costa, M., Sourris, K., Hatzistavrou, T., Elefanty, A.G. & Stanley, E.G. Expansion of human embryonic stem cells in vitro. Curr Protoc Stem Cell Biol. Unit 1F.2 (2007).
Mummery, C.L., Ward, D. & Passier, R. Differentiation of human embryonic stem cells to cardiomyocytes by coculture with endoderm in serum-free medium. Curr. Protoc. Stem Cell Biol. Unit 1F.2 (2007).
Balsam, L.B. et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428, 668–673 (2004).
Brazelton, T.R. & Blau, H.M. Optimizing techniques for tracking transplanted stem cells in vivo. Stem Cells 23, 1251–1265 (2005).
Burns, T.C. et al. Thymidine analogs are transferred from prelabeled donor to host cells in the central nervous system after transplantation: a word of caution. Stem Cells 24, 1121–1127 (2006).
Murry, C.E. et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428, 664–668 (2004).
Nygren, J.M. et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med. 10, 494–501 (2004).
Shultz, L.D. et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J. Immunol. 154, 180–191 (1995).
Bajanca, F., Luz, M., Duxson, M.J. & Thorsteinsdottir, S. Integrins in the mouse myotome: developmental changes and differences between the epaxial and hypaxial lineage. Dev. Dyn. 231, 402–415 (2004).
Acknowledgements
We are grateful to Liesbeth Winter, Krista den Ouden and Sandra Bovens for their help with validation of the MI and MRI protocol, and to Daan Lips for surgical training.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Laake, L., Passier, R., Monshouwer-Kloots, J. et al. Monitoring of cell therapy and assessment of cardiac function using magnetic resonance imaging in a mouse model of myocardial infarction. Nat Protoc 2, 2551–2567 (2007). https://doi.org/10.1038/nprot.2007.371
Published:
Issue Date:
DOI: https://doi.org/10.1038/nprot.2007.371
This article is cited by
-
Cardiomyocyte precursors generated by direct reprogramming and molecular beacon selection attenuate ventricular remodeling after experimental myocardial infarction
Stem Cell Research & Therapy (2023)
-
Cardiac Progenitor Cell–Derived Extracellular Vesicles Reduce Infarct Size and Associate with Increased Cardiovascular Cell Proliferation
Journal of Cardiovascular Translational Research (2019)
-
Circulating Extracellular Vesicles Contain miRNAs and are Released as Early Biomarkers for Cardiac Injury
Journal of Cardiovascular Translational Research (2016)
-
Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as a Model for Heart Development and Congenital Heart Disease
Stem Cell Reviews and Reports (2015)
-
Surgical models for cardiac regeneration in neonatal mice
Nature Protocols (2014)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.